New Cancer Study Results Confirm Lasting Effects on 9/11 First Responders
August 5th 2022Research investigating the physical and mental health consequences of being at the World Trade Center site during and after the terrorist attacks has been instrumental in obtaining health care coverage for thousands of individuals.
Montefiore Einstein Cancer Center Finds CAR T-Cell Therapy Effective in Black and Hispanic Patients
June 2nd 2022Investigators at the Montefiore Einstein Cancer Center report that Black and Hispanic patients had outcomes and side effects following CAR-T treatment that were comparable to their white and Asian counterparts, according to findings from a study published in Bone Marrow Transplantation.
Cancer Dormancy and Tumor Microenvironment Institute to Take Research Efforts to Greater Heights
October 29th 2021The Cancer Dormancy and Tumor Microenvironment Institute, which has recently been launched at Albert Einstein Cancer Center, will focus on taking the tumor microenvironment research being done at the center to the next level and to develop novel technologies that can better identify dormant cancer as well as prevent and control recurrent disease.
Focus on Health Equity in Cancer Care Leads to National Recognition
August 26th 2021Montefiore Einstein Cancer Center has once again earned national recognition for its quality of care studies leading to enhanced patient care, its strong cancer screening and early detection initiatives, and its exceptional support services.
Targeted Therapy Paradigm Grows in NSCLC, While Overcoming Resistance Represents Next Hurdle
June 29th 2021The field of targeted therapy for patients with non–small cell lung cancer has grown exponentially in recent years, with inhibitors for RET, MET exon 14 skipping, and KRAS G12C mutations transforming the paradigm.
Lauren Hackett, MPA, to Lead Operations at NCI-Designated Albert Einstein Cancer Center
June 25th 2021Albert Einstein Cancer Center, Albert Einstein College of Medicine, and Montefiore Health System announced that Lauren Hackett, MPA, has been appointed the deputy director of administration of AECC and associate vice president of cancer medicine at Montefiore Medicine.
Halmos Highlights Effort Exploring COVID-19 Vaccines in Patients With Cancer
June 24th 2021Dr. Halmos discusses the data from a study examining seroconversion rates following COVID-19 vaccination among patients with cancer and underscores the need for novel vaccination or passive immunization strategies for immunosuppressed cohorts.
Halmos Zeroes in on Year Ahead for Lung Cancer Treatment
Balazs Halmos, MD discusses the year 2021 and how it will encompass a bigger focus on neoadjuvant and adjuvant trials, more novel molecular compounds for more select subgroups, and a migration of circulating tumor DNA into a more minimal residual disease–based setting.
Hematologic Malignancies: Co-Chaired by Ulrich Steidl, MD, PhD and Amit Verma, MD
October 20th 2020Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of oncology.
A View From the Frontlines: How a Hospital System Coped With a COVID-19 Peak
August 19th 2020Early in the pandemic, the Montefiore hospital leadership had the forethought and insight to create a reliable and robust outcomes data collection system on all patients with a diagnosis of COVID-19 being seen and treated within the system.